Curriculum vitae for mark cushman - Purdue College of Pharmacy ...

Mark Cushman
68. "A Hexacarboxylic Acid Variant of Cosalane Inhibits CCL5 and CXCL12 Mediated
Cellular Activities," Abstract 2224, 2002 AACR Annual Meeting, San Francisco, April 8,
2002.
69. "The Synthesis of New Indenoisoquinolines: Cytotoxic Agents and Topoisomerase I
Inhibitors," 36 th Graduate Student Symposium in Medicinal Chemistry, Ann Arbor,
Michigan, June 27, 2003.
70. AACR-NCI-EORTC International Conference. Molecular Targets and Cancer
Therapeutics Proceedings, A260, pg.114. November 2003.
71. "Design, Synthesis, and Biological Evaluation of Novel Cytotoxic
Aminoalkenylindenoisoquinoline Topoisomerase I Inhibitors," 227 th American Chemical
Society National Meeting, Anaheim, California, March 28, 2004.
72. "Synthesis of New Indenoisoquinoline: Cytotoxic Agents and Topoisomerase I
Inhibitors," 227 th American Chemical Society National Meeting, Anaheim, California,
March 28, 2004.
73. "Synthesis and Evaluation of Ligands to Probe the Active Site of Lumazine Synthase,"
227 th American Chemical Society National Meeting, Anaheim, California, March 28,
2004.
74. "Exploring the Anticancer Activity of Brefeldin A," Mid-Atlantic Graduate Student
Symposium in Medicinal Chemistry, Purdue University, West Lafayette, Indiana, June
17-19, 2004.
75. "Synthesis of New Indenoisoquinolines: Cytotoxic Agents and Topoisomerase I
Inhibitors," Mid-Atlantic Graduate Student Symposium in Medicinal Chemistry, Purdue
University, West Lafayette, Indiana, June 17-19, 2004.
76. "Design and Synthesis of Indenoisoquinoline Topoisomerase I Inhibitors," Mid-Atlantic
Graduate Student Symposium in Medicinal Chemistry, Purdue University, West
Lafayette, Indiana, June 17-19, 2004.
77. "Design, Synthesis, and Biological Evaluation of Novel Cytotoxic 11-
Aminoalkenylindenoisoquinoline Topoisomerase I Inhibitors," Mid-Atlantic Graduate
Student Symposium in Medicinal Chemistry, Purdue University, West Lafayette, Indiana,
June 17-19, 2004.
78. "Quantum Mechanics Studies on the DNA Sequence Preference of Camptothecin," X.
Xiao and M. Cushman, 229th American Chemical Society National Meeting, San Diego,
California, March 15, 2005.
79. "Design, Synthesis and Metabolic Stabilities of Alkenyldiarylmethanes (ADAMs)
Having Nonidentical Aromatic Substituents as NNRTIs." B-L. Deng and M. Cushman,
229th American Chemical Society National Meeting, San Diego, California, March 16,
2005.
80. "Design, Synthesis, and Evaluation of Dioxane Antiviral Agents Targeted Against the
Hydrophobic Binding Pocket of Syndbis Virus Capsid Protein," H. Y. Kim, R. Warrier,
C. Patkar, R. Kuhn, and M. Cushman, 229th American Chemical Society National
Meeting, San Diego, California, March 16, 2005.
81. "New Indenoisoquinolinium Salts, N-6-Desalkylindenoisoquinolines, and 5,11-
Diketoindenoisoquinolines: Design and Synthesis of Topoisomerase I Inhibitors as
Anticancer Agents," A. S. Ioanoviciu, S. Antony, G. Kohlhagen, Y. Pommier, B. Staker,
L. Stewart, and M. Cushman, 229th American Chemical Society National Meeting, San
Diego, California, March 16, 2005.
82. "On the Binding of Indeno[1,2-c]isoquinolines in the DNA-topoisomerase I Cleavage
Complex," X. Xiao, S. Antony, Y. Pommier, and M. Cushman, 229th American
83.
Chemical Society National Meeting, San Diego, California, March 16, 2005.
"Determining the Mechanisms of Action of Anticancer Natural Products," N. O. Anadu,
Mark S. Cushman, and V. J Davisson, 230 th American Chemical Society National
Meeting, Washington, D. C., August 30, 2005.
84. "Bisindenoisoquinoline (NSC 727357): A Novel Inhibitor of Topoisomerases," Smitha
Antony, Keli K. Agama, Ze-Hong Miao, Muthukaman Nagarajan, Mark Cushman, and
33